Diagnostic tools in autoinflammatory syndromes
With broader awareness about the disease state, early diagnosis and treatment in autoinflammatory syndromes,…
View Resource
IL-1 Inhibition Alters Arthroplasty Rates
A subanalysis of the CANTOS trial suggests that inhibition of interleukin-1β (IL-1β) can reduce…
View Resource
ACR 2020 Reproductive Guidelines – Lactation Guidance
The 2020 American College of Rheumatology (ACR) published guidelines on managing reproductive health issues in rheumatic…
View Resource
Treatments Differ Across Centers in Systemic JIA
Significant variations were seen across hospitals in the treatment of children admitted with new-onset…
View Resource
Canakinumab Tapering in Still's Disease
You can reduce – but not stop – canakinumab therapy in patients who are…
View Resource
Tocilizumab May Benefit COVID-19 Pneumonia
A retrospective, observational study published in Lancet Rheumatology has shown that tocilizumab (TCZ) may reduce…
View Resource
Canakinumab First FDA-Approved Therapy for Adult-Onset Still's Disease
Yesterday, the FDA approved canakinumab (Ilaris) as treatment for adult-onset Still’s disease (AOSD), the…
View Resource
TNR Grand Rounds – Cytokine Storm Syndromes
This week’s Tuesday Nite Rheumatology featured Dr Randy Cron from the University of Alabama –…
View Resource